Correlation between tissue levels of carboxy-terminal propeptide of type I procollagen and clinicopathological characteristics in human colorectal cancer

Hepato-Gastroenterology

Volumn 47, Issue 34, 2000, Pages 1006-1010

  Eroglu, A ^a   Demirci, S ^a   Akbay, A ^a   Sunguroglu, K ^a  

^a NONE   (Turkey)

Author keywords

Colorectal cancer; Type I procollagen, Prognosis

Indexed keywords

PEPTIDE; PROCOLLAGEN C PROTEINASE; TISSUE EXTRACT; TUMOR EXTRACT;

ADULT; AGED; ARTICLE; CANCER INVASION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE LEVEL; TUMOR DIFFERENTIATION;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMAN; IMMUNOASSAY; MALE; MIDDLE AGE; STATISTICS, NONPARAMETRIC;

EID: 0033803567     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Tumor invasion and metastases-Role of the extracellular matrix: Rhoads memorial award lecture
2. Control of cell motility and tumour invasion by extracellular matrix interactions
3. Tumor invasion and the extracellular matrix
4. Analysis of extracellular matrix proteins in biological fluids
5. Tumor invasion and metastasis: An imbalance of positive and negative regulation
6. COOH-terminal propeptides of the major human procollagens. Structural, functional and genetic comparisons
7. The value of biomarkers in detecting alterations in bone metabolism
8. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen
9. Biochemical markers of bone metabolism
10. Collagen propeptides as indicators of collagen assembly
11. The biosynthesis of collagen and its disorders
12. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type 1 procollagen carboxy- and aminotermlnal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer
13. Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma
14. Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients
15. Serum concentration of type I collagen metabolites as a quantitative marker of bone metastases in patients with prostate carcinoma
16. Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissues and peritoneal cavity
17. Type I and type III collagen metabolites in adult osteosarcoma patients
18. Biochemical evaluation of bone turnover in cancer patients with bone metastases: Relationship with radiograph appearances and disease extension
19. Changes of collagen types at various stages of human liver cirrhosis
20. Protein measurement with Folin phenol reagent
21. Recent advances in the study of tumour invasion and metastasis
22. Type I collagen degradation product (ICTP) gives information about the nature of bone metastasis and has prognostic value in prostate cancer
23. Montoring the action of clodronate with type I collagen metabolites in multiple myeloma
24. Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP
25. Immunohistochemical study of type I collagen in benign and malignant ovarian neoplasms
26. Immunohistologic analysis of the extracellular matrix components of the fibrous stroma of human colon cancer
27. N-terminal peptide of type III procollagen